Chondrogenic potential of blood-acquired mesenchymal progenitor cells

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 63, Issue 5, 2010, Pages 841-847

  Raghunath, Joanne ^a,b   Sutherland, Jayne ^c   Salih, Vehid ^d   Mordan, Nicky ^d   Butler, Peter E ^b   Seifalian, Alexander M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cartilage; Chondrogenic; Human; Stem cells

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERING;

ADULT; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE I; COLLAGEN TYPE II; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STEM CELLS; MICROSCOPY, PHASE-CONTRAST; TISSUE AND ORGAN HARVESTING; YOUNG ADULT;

EID: 77950300422     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2009.01.063     Document Type: Article

References (37)

1. Dixon T., Shaw M., Ebrahim S., et al. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need. Ann Rheum Dis 63 (2004) 825-830
2. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthr Cartil 10 (2002) 432-463
3. Raghunath J., Zhang H., Edirisinghe M.J., et al. A new biodegradable nanocomposite based on polyhedral oligomeric silsesquioxane nanocages: cytocompatibility and investigation into electrohydrodynamic jet fabrication techniques for tissue-engineered scaffolds. Biotechnol Appl Biochem 52 (2009) 1-8
4. Kannan R.Y., Salacinski H.J., Sales K., et al. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 26 (2005) 1857-1875
5. Raghunath J., Rollo J., Sales K.M., et al. Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Biochem 46 (2007) 73-84
6. Raghunath J., Georgiou G., Armitage D., et al. Degradation studies on biodegradable nanocomposite based on polycaprolactone/polycarbonate (80:20%) polyhedral oligomeric silsesquioxane. J Biomed Mater Res A (2008)
7. Benya P.D., and Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30 (1982) 215-224
8. Homicz M.R., Schumacher B.L., Sah R.L., et al. Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg 127 (2002) 398-408
9. Dozin B., Malpeli M., Camardella L., et al. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol 21 (2002) 449-459
10. Moskalewski S., and Rybicka E. The influence of the degree of maturation of donor tissue on the reconstruction of elastic cartilage by isolated chondrocytes. Acta Anat (Basel) 97 (1977) 231-240
11. Raghunath J., Salacinski H.J., Sales K.M., et al. Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol 16 (2005) 503-509
12. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
13. Bjornson C.R., Rietze R.L., Reynolds B.A., et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283 (1999) 534-537
14. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 (1999) 10711-10716
15. Sylvester K.G., and Longaker M.T. Stem cells: review and update. Arch Surg 139 (2004) 93-99
16. Stocum D.L. Stem cells in regenerative biology and medicine. Wound Repair Regen 9 (2001) 429-442
17. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
18. Roufosse C.A., Direkze N.C., Otto W.R., et al. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36 (2004) 585-597
19. Punshon G., Sales K.M., Vara D.S., et al. Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. Cell Prolif 41 (2008) 321-335
20. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36 (2004) 568-584
21. Barry F., Boynton R., Murphy M., et al. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 289 (2001) 519-524
22. Wexler S.A., Donaldson C., Denning-Kendall P., et al. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121 (2003) 368-374
23. Kuwana M., Okazaki Y., Kodama H., et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74 (2003) 833-845
24. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2 (2000) 477-488
25. Fernandez M., Simon V., Herrera G., et al. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant 20 (1997) 265-271
26. Lazarus H.M., Haynesworth S.E., Gerson S.L., et al. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother 6 (1997) 447-455
27. Tondreau T., Meuleman N., Delforge A., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23 (2005) 1105-1112
28. Suuronen E.J., Veinot J.P., Wong S., et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 114 (2006) I138-I144
29. Lazarova P., Wu Q., Kvalheim G., et al. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int J Immunopathol Pharmacol 19 (2006) 49-56
30. Freund D., Oswald J., Feldmann S., et al. Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor. Cell Prolif 39 (2006) 325-332
31. Majumdar M.K., Banks V., Peluso D.P., et al. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 185 (2000) 98-106
32. Noth U., Osyczka A.M., Tuli R., et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20 (2002) 1060-1069
33. Barry F., Boynton R.E., Liu B., et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268 (2001) 189-200
34. Indrawattana N., Chen G., Tadokoro M., et al. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 320 (2004) 914-919
35. Stevens M.M., Marini R.P., Martin I., et al. V. FGF-2 enhances TGF-beta1-induced periosteal chondrogenesis. J Orthop Res 22 (2004) 1114-1119
36. De B.C., Dell'Accio F., and Luyten F.P. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44 (2001) 85-95
37. Rhodes N.P., Srivastava J.K., Smith R.F., et al. Heterogeneity in proliferative potential of ovine mesenchymal stem cell colonies. J Mater Sci Mater Med 15 (2004) 397-402